13 March 2025 in Journal of the American Heart Association
Background: Heart failure with preserved ejection fraction (HFpEF) constitutes more than half of all HF but has few effective therapies. Recent human myocardial transcriptomics and metabolomics have identified major differences between HFpEF and controls. How this translates at the protein level is unknown. Methods and Results: Myocardial tissue from patients with HFpEF and nonfailing donor controls was analyzed by data‐dependent acquisition (n=10 HFpEF, n=10 controls) and data‐independent acquisition (n=44 HFpEF, n=5 controls) mass spectrometry‐based proteomics. Differential protein expression analysis, pathway overrepresentation, weighted coexpression network analysis, and machine learning were integrated with clinical characteristics and previously reported transcriptomics. Principal component analysis (data‐dependent acquisition‐mass spectrometry) found HFpEF separated into 2 subgroups: one similar to controls and the other disparate. Downregulated proteins in HFpEF versus controls were enriched in mitochondrial transport/organization, translation, and metabolism including oxidative phosphorylation. Proteins upregulated in HFpEF were related to immune activation, reactive oxygen species, and inflammatory response. Ingenuity pathway analysis predicted downregulation of protein translation, mitochondrial function, and glucose and fat metabolism in HFpEF. Expression of oxidative phosphorylation and metabolism genes (higher) versus proteins (lower) was discordant in HFpEF versus controls. Data‐independent acquisition‐mass spectrometry proteomics also yielded 2 HFpEF subgroups; the one most different from controls had a higher proportion of patients with severe obesity and exhibited lower proteins related to fuel metabolism, oxidative phosphorylation, and protein translation. Three modules of correlated proteins in HFpEF that correlated with left ventricular hypertrophy and right ventricular load related to (1) proteasome; (2) fuel metabolism; and (3) protein translation, oxidative phosphorylation, and sarcomere organization. Conclusions: Integrative proteomics, transcriptomics, and pathway analysis supports a defect in both metabolism and translation in HFpEF. Patients with HFpEF with more distinct proteomic signatures from control more often had severe obesity, supporting therapeutic efforts targeting metabolism and translation, particularly in this subgroup.
31 March 2023 in PLOS Computational Biology
Advances in long-read sequencing technologies have dramatically improved the contiguity and completeness of genome assemblies. Using the latest nanopore-based sequencers, we can generate enough data for the assembly of a human genome from a single flow cell. With the long-read data from these sequences, we can now routinely produce de novo genome assemblies in which half or more of a genome is contained in megabase-scale contigs. Assemblies produced from nanopore data alone, though, have relatively high error rates and can benefit from a process called polishing, in which more-accurate reads are used to correct errors in the consensus sequence. In this manuscript, we present a novel tool for genome polishing called JASPER (Jellyfish-based Assembly Sequence Polisher for Error Reduction). In contrast to many other polishing methods, JASPER gains efficiency by avoiding the alignment of reads to the assembly. Instead, JASPER uses a database of k-mer counts that it creates from the reads to detect and correct errors in the consensus. Our experiments demonstrate that JASPER is faster than alignment-based polishers, and both faster and more accurate than other k-mer based polishing methods. We also introduce the idea of using a polishing tool to create population-specific reference genomes, and illustrate this idea using sequence data from multiple individuals from Tokyo, Japan.
29 May 2024 in Computers in Biology and Medicine
21 September 2026 in F1000Research
Background Long-read RNA sequencing technologies can produce complete or near-complete transcript sequences. Recently introduced methods for direct RNA and cDNA sequencing can provide a high-throughput strategy for the discovery of novel and rare gene isoforms. However, the high error rates in ONT sequences limit the ability to exactly pinpoint splice site boundaries when aligning reads to the genome. Methods In this paper, we present a novel tool called NIFFLR (Novel IsoForm Finder using Long Reads) that identifies and quantifies both known and novel isoforms using long-read RNA sequencing data. NIFFLR recovers known transcripts and assembles novel transcripts present in the data by aligning exons from a reference annotation to the long reads. Results NIFFLR effectively recovers correct transcripts from simulated reads based on known transcript annotations, achieving higher sensitivity and precision compared to several previously published tools. On real data, NIFFLR shows high accuracy as measured by concordance of isoform counts to the counts computed from Illumina data for the same sample. We applied NIFFLR to a set of 92 GTEx long-read samples and produced transcript counts for both novel and known isoforms. In total, we identified and quantified 119,928 isoforms present in the RefSeq annotation of GRCh38 and 42,868 novel isoforms across 10,487 genes, more than previous studies identified in this dataset. Conclusions NIFFLR is an effective tool aimed at assembly and quantification of transcripts present in the long, high error transcriptome reads. NIFFLR is released under an open-source license (GPL 3.0) and is available on GitHub at https://github.com/alguoo314/NIFFLR/releases, and from BioConda as “nifflr”.